Vaccine experts — including those who serve on advisory committees for the US Food and Drug Administration and the US Centers for Disease Control and Prevention — have questions about data released Monday by AstraZeneca about its Covid-19 vaccine.
AstraZeneca Covid vaccine: Experts have questions about the Phase 3 trial data
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over